Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine in PTSD
NCT02398136Phase 3Withdrawn
- Start
- Dec 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ketamine in post-traumatic stress disorder (PTSD). Planned start Dec 2014; status: withdrawn.
02
Drugs
ketamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02398136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02398136.